CD44 in human glioma correlates with histopathological grade and cell migration

Pathology International

Volumn 62, Issue 7, 2012, Pages 463-470

  Yoshida, Tsuneyasu ^a   Matsuda, Yoko ^a   Naito, Zenya ^a   Ishiwata, Toshiyuki ^a  

^a NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

CD44; Cell growth; Glioblastoma; Glioma; Migration

Indexed keywords

HERMES ANTIGEN; MESSENGER RNA; MONOCLONAL ANTIBODY;

ARTICLE; ASTROCYTE; ASTROCYTOMA; BRAIN TISSUE; CANCER GRADING; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CORRELATION ANALYSIS; FEMALE; FETUS; GLIOBLASTOMA; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION;

ANTIBODIES, BLOCKING; ANTIGENS, CD44; BRAIN; BRAIN NEOPLASMS; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; FEMALE; GLIOBLASTOMA; HUMANS; KI-67 ANTIGEN; MALE; NEOPLASM STAGING; TUMOR MARKERS, BIOLOGICAL;

EID: 84862873512     PISSN: 13205463     EISSN: 14401827     Source Type: Journal    
DOI: 10.1111/j.1440-1827.2012.02823.x     Document Type: Article

References (38)

1. Louis DN, Ohgaki H, Wiestler OD etal. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007; 114: 97-109.
2. Brem SS, Bierman PJ, Black P etal. Central nervous system cancers: Clinical practice guidelines in oncology. J Natl Compr Canc Netw 2005; 3: 644-90.
3. Bondy ML, Scheurer ME, Malmer B etal. Brain tumor epidemiology: Consensus from the brain tumor epidemiology consortium. Cancer 2008; 113: 1953-68.
4. Tews DS, Nissen A. Expression of adhesion factors and degrading proteins in primary and secondary glioblastomas and their precursor tumors. Invasion Metastasis 1998; 18: 271-84.
5. Rooprai HK, Vanmeter T, Panou C etal. The role of integrin receptors in aspects of glioma invasion in vitro. Int J Dev Neurosci 1999; 17: 613-23.
6. Schunemann DP, Grivicich I, Regner A etal. Glutamate promotes cell growth by EGFR signaling on U-87MG human glioblastoma cell line. Pathol Oncol Res 2009; 16: 285-93.
7. Okamoto I, Kawano Y, Murakami D etal. Proteolytic release of CD44 intracellular domain and its role in the CD44 signaling pathway. J Cell Biol 2001; 155: 755-62.
8. Okamoto I, Kawano Y, Tsuiki H etal. CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration. Oncogene 1999; 18: 1435-46.
9. Okamoto I, Tsuiki H, Kenyon LC etal. Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors. Am J Pathol 2002; 160: 441-7.
10. Stamenkovic I, Yu Q. Shedding light on proteolytic cleavage of CD44: The responsible sheddase and functional significance of shedding. J Invest Dermatol 2009; 129: 1321-4.
11. Wei KC, Huang CY, Chen PY etal. Evaluation of the prognostic value of CD44 in glioblastoma multiforme. Anticancer Res 2010; 30: 253-9.
12. Anido J, Saez-Borderias A, Gonzalez-Junca A etal. TGF-beta Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. Cancer Cell 2010; 18: 655-68.
13. Ylagan LR, Quinn B. CD44 expression in astrocytic tumors. Mod Pathol 1997; 10: 1239-46.
14. Nagasaka S, Tanabe KK, Bruner JM, Saya H, Sawaya RE, Morrison RS. Alternative RNA splicing of the hyaluronic acid receptor CD44 in the normal human brain and in brain tumors. J Neurosurg 1995; 82: 858-63.
15. Huh JW, Kim HR, Kim YJ etal. Expression of standard CD44 in human colorectal carcinoma: Association with prognosis. Pathol Int 2009; 59: 241-6.
16. Kuncova J, Urban M, Mandys V. Expression of CD44s and CD44v6 in transitional cell carcinomas of the urinary bladder: Comparison with tumour grade, proliferative activity and p53 immunoreactivity of tumour cells. APMIS 2007; 115: 1194-205.
17. Faleiro-Rodrigues C, Lopes C. E-cadherin, CD44 and CD44v6 in squamous intraepithelial lesions and invasive carcinomas of the uterine cervix: An immunohistochemical study. Pathobiology 2004; 71: 329-36.
18. Cho EY, Choi Y, Chae SW, Sohn JH, Ahn GH. Immunohistochemical study of the expression of adhesion molecules in ovarian serous neoplasms. Pathol Int 2006; 56: 62-70.
19. Ricardo S, Vieira AF, Gerhard R etal. Breast cancer stem cell markers CD44, CD24 and ALDH1: Expression distribution within intrinsic molecular subtype. J Clin Pathol 2011; 64: 937-946.
20. Idowu MO, Kmieciak M, Dumur C etal. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol 2012; 43: 364-373.
21. Drillenburg P, Wielenga VJ, Kramer MH etal. CD44 expression predicts disease outcome in localized large B cell lymphoma. Leukemia 1999; 13: 1448-55.
22. Brown RL, Reinke LM, Damerow MS etal. CD44 splice isoform switching in human and mouse epithelium is essential for epithelial-mesenchymal transition and breast cancer progression. J Clin Invest 2011; 121: 1064-74.
23. Matsuda Y, Fujii T, Suzuki T etal. Comparison of fixation methods for preservation of morphology, RNAs, and proteins from paraffin-embedded human cancer cell-implanted mouse models. J Histochem Cytochem 2011; 59: 68-75.
24. Ishiwata T, Teduka K, Yamamoto T, Kawahara K, Matsuda Y, Naito Z. Neuroepithelial stem cell marker nestin regulates the migration, invasion and growth of human gliomas. Oncol Rep 2011; 26: 91-9.
25. Park JB, Kwak HJ, Lee SH. Role of hyaluronan in glioma invasion. Cell Adh Migr 2008; 2: 202-7.
26. Xu Y, Stamenkovic I, Yu Q. CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res 2010; 70: 2455-64.
27. Kuppner MC, Van Meir E, Gauthier T, Hamou MF, de Tribolet N. Differential expression of the CD44 molecule in human brain tumours. Int J Cancer 1992; 50: 572-7.
28. Merzak A, Koocheckpour S, Pilkington GJ. CD44 mediates human glioma cell adhesion and invasion in vitro. Cancer Res 1994; 54: 3988-92.
29. Koochekpour S, Pilkington GJ, Merzak A. Hyaluronic acid/CD44H interaction induces cell detachment and stimulates migration and invasion of human glioma cells in vitro. Int J Cancer 1995; 63: 450-4.
30. Naor D, Sionov RV, Ish-Shalom D. CD44: Structure, function, and association with the malignant process. Adv Cancer Res 1997; 71: 241-319.
31. Jijiwa M, Demir H, Gupta S etal. CD44v6 Regulates Growth of Brain Tumor Stem Cells Partially through the AKT-Mediated Pathway. PLoS ONE 2011; 6: e24217.
32. Hebbard L, Steffen A, Zawadzki V etal. CD44 expression and regulation during mammary gland development and function. J Cell Sci 2000; 113: 2619-30.
33. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003; 100: 3983-8.
34. Dalerba P, Dylla SJ, Park IK etal. Phenotypic characterization of human colorectal cancer stem cells. Proc Natl Acad Sci USA 2007; 104: 10158-63.
35. Bar EE. Glioblastoma, cancer stem cells and hypoxia. Brain Pathol 2011; 21: 119-29.
36. Galli R, Binda E, Orfanelli U etal. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 2004; 64: 7011-21.
37. Zhang LZ, Zhang CQ, Yan ZY, Yang QC, Jiang Y, Zeng BF. Tumor-initiating cells and tumor vascularization. Pediatr Blood Cancer 2011; 56: 335-40.
38. Cheng L, Bao S, Rich JN. Potential therapeutic implications of cancer stem cells in glioblastoma. Biochem Pharmacol 2010; 80: 654-65.